Fertility Market
Report ID: SQMIG35D2475
Report ID: SQMIG35D2475
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35D2475 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
181
|Figures:
79
Global Fertility Market size was valued at USD 32.30 Billion in 2024 and is poised to grow from USD 35.10 Billion in 2025 to USD 68.32 Billion by 2033, growing at a CAGR of 8.7% during the forecast period (2026-2033).
The fertility market trends includes assisted reproductive technologies, diagnostics, pharmaceuticals, donor services that enable individuals and couples to conceive when natural reproduction is impaired or postponed. Its primary driver is the demographic and social shift toward later childbearing, which raises infertility incidence and fuels demand for IVF, ICSI and cryopreservation. The declining birth rate in relation to labor force and social systems means it’s an important market because successful reproductive treatments allow for reproductive autonomy, therefore establishing an ecosystem of clinics, pharmaceutical companies, and fertility banks. Recent years have brought innovations including pre-implantation genetic testing (PGT), vitrification (freezing embryos), awareness, and various insurance options to realize geographic and scaled expansion from pre-existing clinical processes to the availability of fertility services.
Improving clinical outcomes as a result of technology (e.g., time lapse embryo imaging, PGT) provides real-world commercial opportunities by increasing success rates over a greater number of cycles, thereby lowering cumulative costs for patients. Clinics can also increase their ability to provide fertility services by creating additional customers. Therefore, as corporate fertility benefits increase usage, egg freezing programs attract career-oriented women from metropolitan areas. In the meantime, varying costs and regulations drive fertility tourism to countries like Spain and India thereby facilitating connectivity between regional clinics and international investment in automation; data analysis and personalized protocols.
How is AI Improving Treatment Personalization in the Fertility Market?
AI is enhancing personalization in fertility, leveraging patient history, hormone profiles, imaging and lab data to customize stimulation, embryo selection and timing of transfer. Key elements are predictive models guiding protocol choice, image based embryo scoring adding objectivity and workflow tools standardizing lab practice. As clinics seek more consistent results and improved patient experience, they are moving from experimental pilots to wider clinical use. Examples include AI driven embryo assessment, time lapse analytics and scheduling systems that align treatment steps to individual biology making care more patient centered and more efficient.Regulated AI can help us improve embryo ranking and timing of cycles.
Alife Health’s Embryo Predict tool received FDA clearance in May 2026. This validation supports wider clinical adoption, increases clinician confidence and improves lab efficiency by providing reproducible, data driven decision support.
Market snapshot - (2026-2033)
Global Market Size
USD 32.3 Billion
Largest Segment
Assisted Reproductive Technology (ART)
Fastest Growth
Fertility Preservation
Growth Rate
8.68% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global fertility market is segmented by treatment type, product & service type, procedure type, patient type, end user, distribution channel and region. Based on treatment type, the market is segmented into assisted reproductive technology (ART), artificial insemination, fertility preservation and fertility drugs & hormonal therapy. Based on product & service type, the market is segmented into fertility drugs, fertility consumables & media, fertility equipment, fertility testing & diagnostics and fertility clinic services. Based on procedure type, the market is segmented into fresh non-donor cycles, frozen non-donor cycles, donor egg cycles, donor embryo cycles and gestational carrier cycles. Based on patient type, the market is segmented into female infertility, male infertility, combined infertility, unexplained infertility and single parents & LGBTQ+ families. Based on end user, the market is segmented into fertility clinics, hospitals, surgical centers, cryobanks & fertility preservation centers and research institutes. Based on distribution channel, the market is segmented into direct tender & institutional sales, retail pharmacies, specialty pharmacies and online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Assisted reproductive technology segment dominates because it encompasses the core clinical procedures driving fertility outcomes, including IVF and ICSI, which command intensive clinical resources and specialized expertise. Its centrality creates sustained demand for clinics, skilled embryologists, advanced lab infrastructure and downstream products, reinforcing investment and service consolidation. Technological refinements and outcome-focused patient decision making further concentrate clinical volume and revenue around ART procedures, making it the principal market anchor.
The fastest growing area is fertility preservation. More and more people want to be parents on their own timeline and that's why the patient population is increasing so quickly; the other driver of that growth is patients undergoing treatments that have a high $ risk to their fertility due to the adverse effects of the treatment itself. In addition, advancements in cryopreservation better storage protocols, more employer-sponsored cryobank services, etc. will continue to expand not only the capacity of cryobanks to provide these types of services but will also create new revenue streams for cryobanks and provide a longer-term patient engagement opportunity.
The most recognized segment will likely be fertility testing & diagnostics, as the value of diagnostic accuracy is the foundation of personalized treatment pathways, thus providing clinicians with an approach to determine the best protocol to use and how to allocate resources. In addition, by decreasing clinical uncertainty, increasing the appropriateness of procedures and supporting outcome-driven care, robust testing (ovarian reserve, genetic screening, semen analysis, etc.) will create interdependencies with therapeutic and non-therapeutic services and will position diagnostics as a strategic differentiator between markets. The investment of laboratory capabilities and diagnostics software will facilitate the adoption of diagnostic capabilities in a variety of clinics.
Meanwhile, fertility equipment is the most rapidly expanding area as clinics modernize labs with automated incubators, time-lapse imaging and micro-manipulation tools. Innovation raises cycle efficiency, reduces manual variability and supports higher throughput, prompting capital investment and creating aftermarket demand for consumables and technical service agreements.
To get detailed segments analysis, Request a Free Sample Report
North America commands the global fertility market growth through a combination of advanced clinical infrastructure, concentration of leading fertility clinics and technology developers, and high patient access to specialist care. Assisted reproductive technologies are innovative and supported by robust public and private funding mechanisms. A strong regulatory framework allows safe adoption of novel treatments. Rapid clinical translation of new protocols and devices is supported by strong academic research networks and industry partnerships. Furthermore, patient awareness and demand for fertility preservation and advanced reproductive solutions support market depth. The region is the reference market for clinical excellence and commercial leadership due to high standards of quality control, the wide diagnostic capabilities and the availability of trained reproductive specialists. The region’s commercial ecosystems support scalable service delivery models and specialized ancillary services. Biotech companies, clinics and laboratories join forces to improve patient pathways and commercialize opportunities.
Fertility market share in the United States is characterized by a dense network of specialist clinics, advanced laboratory services, and a strong private sector that sponsors clinical innovation. Patient access to a wide range of assisted reproductive procedures is supported by comprehensive diagnostic pathways and culture of adoption. Collaboration between academic centers, biotech companies, and payers fosters development of new treatment protocols, while patient education drives demand for personalized fertility care.
Fertility market forecast in Canada will be delivered through integrated public and private pathways that focus on equitable access for all patients, as well as achieving high-quality clinical care. A wide range of assisted reproduction services has been developed using highly trained reproductive specialists and fertility centres, along with associated laboratories. Collaborations with research hospitals provide clinical education and support continued improvement of providers’ clinical education. The patient advocacy and provider-led initiatives are designed to improve the coordination of care offered to patients, increase the quality and quantity of counselling services provided to patients and increase the number of reproductive options available to patients through provincial efforts.
Rapid growth is being observed in the Asia Pacific fertility market outlook on account of growing patient awareness, increasing investments in reproductive healthcare infrastructure, and increasing accessibility of advanced assisted reproductive technologies by domestic and international providers. The increasing demand for fertility preservation and treatment by urban populations is leading to the expansion of clinics and diversification of services. Policymaker attention, private sector engagement, and entry of specialized diagnostics and lab service providers improve access and quality. Local biotech innovation and adaptation of protocols to regional patient profiles speed up clinical uptake. Cross-border reproductive services and medical tourism push patient flows further. The improvements to equipment are backed by investing in training of embryologists and reproductive specialists that increases the reliability of services and patient confidence. These factors together create a dynamic regional environment where capacity building, technology transfer and commercialization combine to provide sustained impetus to the market.
Fertility market regional outlook in Japan is defined by a strong emphasis on evidence-based reproductive medicine, advanced laboratory capabilities, and specialized clinics that prioritize patient-centered care. Clinical excellence is supported by investment in training, diagnostic services and the integration of new treatment modalities. Healthcare organizations work with local biotech companies to create customized solutions for local patient needs. Policy attention helps to improve services and quality assurance systems help to improve treatment pathways and outcomes.
Fertility market regional forecast in South Korea stands out through the use of advanced assisted reproductive technologies, stringent embryology laboratory standards, and a highly competitive clinic environment that spurs innovation in services. Strong private investment and partnerships with technology providers speed access to diagnostics and treatment options. Integrated care pathways and specialized counseling improve coordination. National initiatives support capacity building and quality assurance, improving clinical consistency and patient confidence across the health system.
Europe is establishing itself as the leader for fertility through a coordinated policy focus, clinical research investments and quality standards harmonisation amongst centres of excellence. There are academic networks and specialty fertility clinics supporting evidence-based practice as well as development of best-practice; and there are also collaborative initiatives by public / private sectors supporting integrated care pathways. There is greater trust and safety by focussing on patient rights, obtaining informed consent and providing regulatory oversight. Regional partnerships and cross-border collaborations facilitate innovations in diagnostic, cryopreservation, and laboratory services. Targeted funding mechanisms to support translational research, workforce development programs for embryologists and reproductive specialists, and industry collaboration will grow capacity, and encourage adoption of innovative treatment models. These drivers will create a balanced market characterized by a combination of clinical rigor, patient-centeredness, and delivery of services in a sustainable manner, resulting in the region becoming a competitive leader in providing the highest level of advanced reproductive healthcare.
Fertility market analysis in Germany is driven by a strong clinical research base, regulated laboratory standards, and integrated hospital-clinic networks that prioritize evidence-based practice. Specialist training and robust quality assurance frameworks support consistent clinical outcomes. Collaboration between academic centers, diagnostics providers, and biotech firms fosters innovation adapted to local regulatory pathways. Patient counseling and coordinated care models emphasize informed decision making, continuity of care, and integration of supportive reproductive services delivery.
Fertility industry in the United Kingdom there is a wide variety of reproductive health care options from both public and private providers. There are many different ways to deliver services and give patients their own pathway to treatment. The emphasis on clinical governance, transparency, and patient protection fosters trust in the delivery of care. Research-intensive institutions collaborate with industry partners to improve the diagnostic capabilities and laboratory protocols for clinics and hospitals offering fertility services. Professional accreditation and continued professional development ensure practitioners operate at a high standard, while also having patient advocacy organisations working to influence public policy and advocate for equal accessibility to comprehensive reproductive services.
Fertility market penetration in France is supported by solid public health systems, extensive clinic networks, and a long-standing emphasis on clinical research to provide evidence-based treatment options. The integrated care pathways include obstetrical, reproductive, and supportive counseling services to provide an integrated approach for patients receiving fertility treatment. Collaboration between private industry and government supports the development of laboratory facilities and diagnostics that improve the availability of services for patients. Efforts at patient-centered counseling, ethical oversight, regional collaboration, and professional societies will help ensure that there is a balance between access and quality, while providing standards for developing clinical training programs.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Infertility Prevalence
Advances In Assisted Reproduction
High Treatment Costs
Regulatory Complexity and Variability
Request Free Customization of this report to help us to meet your business objectives.
Competitive forces are shaping the global fertility market, driven by clinic consolidation, private equity rollups and technology differentiation, with tangible actions including IVI RMA North America’s acquisition of three California practices in January 2025 and Amulet Capital Partners’ acquisition of Genetics and IVF Institute in 2024. Technology plays include AI and robotics innovations and cryostorage IP acquisitions. Employer partnerships for benefits broaden demand and channel reach.
Top Player’s Company Profile
Recent Developments in the Fertility Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global fertility market is propelled primarily by demographic shifts to later childbearing that increase demand for assisted reproductive services, while high treatment costs remain a major restraint limiting access and broader adoption. North America leads the market given its advanced clinical infrastructure and payer models, with Assisted Reproductive Technology remaining the dominant segment because IVF, ICSI and related lab services anchor clinic revenues and innovation. A secondary growth driver is rapid technological progress including AI-driven embryo assessment, vitrification and diagnostics that improve per-cycle success and enable scale. Together these forces shape investment, consolidation and improved patient access across regions.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 32.3 Billion |
| Market size value in 2033 | USD 68.32 Billion |
| Growth Rate | 8.68% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Fertility Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Fertility Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Fertility Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Fertility Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Fertility Market size was valued at USD 32.3 Billion in 2024 and is poised to grow from USD 35.1 Billion in 2025 to USD 68.32 Billion by 2033, growing at a CAGR of 8.68% during the forecast period (2026-2033).
Competitive dynamics in the global fertility market are driven by clinic consolidation, private equity rollups and technology differentiation, with concrete moves such as IVI RMA North America’s January 2025 acquisition of three California practices and Amulet Capital Partners’ 2024 purchase of Genetics and IVF Institute. Technology plays include AI and robotics innovations and cryostorage IP acquisitions, while employer partnerships for benefits broaden demand and channel reach. 'CooperSurgical', 'Vitrolife Group', 'FUJIFILM Irvine Scientific', 'Hamilton Thorne', 'Cook Medical', 'Thermo Fisher Scientific', 'Kitazato Corporation', 'Esco Medical', 'Genea Biomedx', 'Progyny', 'IVI RMA Global', 'Virtus Health', 'Monash IVF Group', 'Merck KGaA', 'Ferring Pharmaceuticals', 'Organon', 'Gedeon Richter', 'Bloom IVF Group', 'Apollo Fertility', 'Gaudium IVF'
Rising infertility rates have expanded demand for diagnostic, therapeutic, and supportive fertility services by increasing the pool of individuals seeking intervention. This heightened need drives service adoption as clinics and laboratories scale capacity and diversify treatment options to accommodate varied patient profiles. Providers invest in technology and training to improve success rates, which in turn attracts more patients and encourages earlier medical consultation. The cumulative effect strengthens overall market demand by creating sustained utilization of products, procedures, and ancillary services across regions.
Digital And Telehealth Integration: Fertility services increasingly adopt telehealth and digital tools to extend care beyond clinic visits. Virtual consultations, remote monitoring, and patient apps enable continuous engagement and personalized treatment journeys while improving access for geographically dispersed patients. Integration of electronic records and interoperable data supports coordinated care across clinicians and diagnostics, streamlining decision making and follow up. These digital channels reshape clinic workflows, require new staff competencies, and create opportunities for differentiated patient centric offerings that prioritize convenience, transparency, and therapeutic relationships.
Why does North America Dominate the Global Fertility Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
